Back
EHRA Premium Access

Long-term outcomes in hybrid versus standalone thoracoscopic ablation in patients with atrial fibrillation: a systematic review and reconstructed individual patient data meta-analysis.

Session: Atrial fibrillation: treatment 2
Topic: Rhythm Control, Atrial Fibrillation Surgery
Speaker: Miss L. Aerts (Maastricht, NL)
Event: EHRA 2024

Congress Presentation

About the speaker

Miss Luca Aerts

Maastricht University Medical Center+, Maastricht (Netherlands (The))
0 follower

8 more presentations in this session

Hybrid ablation versus repeated catheter ablation in persistent atrial fibrillation: long-term results of the HARTCAP-AF trial.

Speaker: Ms C. van der Heijden (Maastricht, NL)

Access
Abstract
Slides
Video
Thumbnail

Intra-procedural three-dimensional rotational angiography in cryoballoon ablation of atrial fibrillation - results from a randomised clinical trial

Speaker: Doctor I. Prepolec (Zagreb, HR)

Access
Abstract
Slides
Video
Thumbnail

The hybrid ablation approach to treating long-standing persistent atrial fibrillation: real-world data from a tertiary institution

Speaker: Doctor V. Lim (Coventry, GB)

Access
Abstract
Slides
Video
Thumbnail

LINAC-Based STereotactic Arrhythmia Radioablation (STAR) for paroxysmal atrial fibrillation in elderly: a prospective phase II trial

Speaker: Doctor I. Romanazzi (Acquaviva Delle Fonti, IT)

Access
Abstract
Slides
Video
Thumbnail

Two-year safety and effectiveness of hybrid ablation versus catheter ablation in patients with non-paroxysmal AF: mid-term results of the CEASE-AF trial

Speaker: Doctor M. Wijffels (Nieuwegein, NL)

Access
Abstract
Slides
Video
Thumbnail

Access the full session

Atrial fibrillation: treatment 2

Speakers: Miss L. Aerts, Ms C. van der Heijden, Doctor I. Prepolec, Doctor V. Lim, Doctor I. Romanazzi...
Access
Thumbnail

About the event

Image

EHRA 2024

7 April - 9 April 2024

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb